Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Long-term Extension Study to Evaluate the Safety, Tolerability, and Efficacy of AL002 in Participants With Alzheimer's Disease

NCT05744401 is registered in ClinicalTrials.gov with Alector Inc. as lead sponsor.

NCT NCT05744401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05744401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Long-term Extension Study to Evaluate the Safety, Tolerability, and Efficacy of AL002 in Participants With Alzheimer's Disease
Lead sponsor
Alector Inc.
Phase
Phase 2
Overall status
Terminated
Start date
January 4, 2023
Completion date
February 5, 2025
Enrollment
197 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease